Pfizer announced topline data for the Phase 3 SPIRE-AI (AutoInjector) trial where bococizumab given as a prefilled pen met its co-primary endpoints.
The Endocrine Society has issued a statement advising clinicians to avoid administering compounded hormone medications to treat menopausal symptoms, female sexual dysfunction, and other hormone conditions.
Expecting mothers should make sure they get enough vitamin D exposure during the second trimester to reduce the child's likelihood of developing asthma, according to new research by the University of Kansas published in the American Journal of Health Economics.
Coffee consumption may lower the risk of colorectal cancer, according to findings from a new study published in Cancer Epidemiology, Biomarkers & Prevention.
According to a new Centers for Disease Control and Prevention (CDC) report, the prevalence of autism spectrum disorder (ASD) has not largely changed from 2 years ago with a rate of 1 in 68 children (1.46%).
Cambrooke Therapeutics announced the launch of KetoVie Peptide, the first ketogenic hydrolyzed whey-based (peptides) formula for patients on a ketogenic diet with milk protein sensitivities and/or impaired digestive function.
Sleep problems in young adults may predict chronic pain and worsening pain severity over time, a new study published in PAIN has shown.
Drugs that were once considered safe for pregnant women with migraines may not be, according to researcher at Wake Forest Baptist Medical Center.
AstraZeneca announced that Brilinta (ticagrelor) is now preferred over clopidogrel for the management of patients with acute coronary syndrome (ACS) who have received a coronary stent and in non-ST elevation acute coronary syndrome (NSTE-ACS) patients treated with medical therapy alone.
Extended-release naltrexone is associated with a lower rate of opioid relapse than usual treatment among criminal justice offenders, according to a study published in the New England Journal of Medicine.
The Food and Drug Administration (FDA) announced the availability of an investigational test by Roche Molecular Systems to screen blood donations for Zika virus.
Acadia announced that the Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) voted in favor (12-2) that the benefits of Nuplazid (primavanserin) outweighed the risks for the treatment of psychosis associated with Parkinson's' disease.
The American College of Cardiology (ACC) and the American Heart Association (AHA) issued updated guidelines for dual antiplatelet therapy in patients with coronary artery disease (CAD).
Researchers from Beth Israel Deaconess Medical Center, Boston, developed a clinical prediction score with modest accuracy in assessing ischemic and bleeding risks with dual antiplatelet therapy following coronary stent placement. Findings from the study are published in JAMA.
Takeda and Lundbeck announced that the FDA has issued a complete response letter for the sNDA regarding the addition of new clinical trial data to the Brintellix (vortioxetine) labeling for treating certain aspects of cognitive dysfunction in adults with major depressive disorder (MDD).
Adherence to a Mediterranean diet is associated with reduced risk of hip fracture, according to a study published online in JAMA Internal Medicine.
Rheumatoid arthritis (RA) patients have a greater prevalence and severity of periodontitis than the non-arthritis population, according to a new study published in the Korean Journal of Internal Medicine.
Patients with Staphylococcus aureus skin and soft tissue infections took an average of 57% of their antibiotic doses after being discharged from the hospital, a new study published in Antimicrobial Agents and Chemotherapy reported.
In a recent study published in Pediatrics, researchers suggested that increased breastfeeding, vaccine administration, and lower rates of smoking may be major factors in the reduced rate of ear infections in babies.
Adolescents and young adults with autism spectrum disorder (ASD) are more likely to develop type 2 diabetes mellitus (T2DM), according to a study published online in Diabetes Care.
Kedrion Biopharma announced that the Food and Drug Administration (FDA) has approved the packaging of Koate Double Viral Inactivation (DVI) Antihemophilic Factor (human) with Mix2Vial, a needle-free transfer device.
When doctors in the United States prescribe opioids for their patients, 99% of them hand out prescriptions that exceed the federally recommended three-day dosage limit, new research suggests.
Tec Labs announced the launch of Tecnu Bites & Stings Medicated Itch and Pain Relief Wipes for treating insect bites and bee stings.
Aprecia announced that Spritam (levetiracetam) tablets for oral suspension are now available as adjunctive therapy in the treatment of partial-onset seizures in patients ≥4 years old, myoclonic seizures in patients ≥12 years old, and primary generalized tonic-clonic seizures in patients ≥6 years old.
Rosacea is associated with an increased risk for Parkinson's disease, according to research published online in JAMA Neurology.
Hospira announced a voluntary recall of one lot of Sodium Bicarbonate Injection 8.4%, USP, due to particulate presence within a single-dose glass fliptop vial from a confirmed complaint.
A new study in JAMA Internal Medicine indicated that since 2005, the risk of major drug interaction in older adults has increased in those taking multiple prescriptions and dietary supplements concurrently.